http://debianws.lexgopc.com/wiki143/index.php?action=history&feed=atom&title=CP_55%2C244
CP 55,244 - Revision history
2026-05-15T17:42:05Z
Revision history for this page on the wiki
MediaWiki 1.43.1
http://debianws.lexgopc.com/wiki143/index.php?title=CP_55,244&diff=6656366&oldid=prev
imported>Arthurfragoso: dark mode fix
2025-01-11T16:36:24Z
<p>dark mode fix</p>
<p><b>New page</b></p><div>{{Short description|Chemical compound}}<br />
{{cs1 config|name-list-style=vanc|display-authors=6}}<br />
{{Drugbox<br />
| verifiedrevid = 451979965<br />
| IUPAC_name = (2''S'',4''S'',4a''S'',6''R'',8a''R'')-6-(Hydroxymethyl)-4-[2-hydroxy-4-(2-methyloctan-2-yl)phenyl]-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-ol<br />
| image = CP-55,244.svg<br />
| image_class = skin-invert-image<br />
<br />
<!--Clinical data--><br />
| tradename = <br />
| legal_status = <br />
| routes_of_administration = <br />
<br />
<!--Pharmacokinetic data--><br />
| metabolism = <br />
| elimination_half-life = <br />
| excretion = <br />
<br />
<!--Identifiers--><br />
| CAS_number_Ref = {{cascite|correct|CAS}}<br />
| CAS_number = 79678-32-3<br />
| UNII_Ref = {{fdacite|correct|FDA}}<br />
| UNII = 3HMR7H9HX8<br />
| PubChem = 133254<br />
| ChemSpiderID = 117567<br />
<br />
<!--Chemical data--><br />
| C=26 | H=42 | O=3 <br />
| smiles = CCCCCCC(C)(C)c1ccc(c(c1)O)[C@H]2C[C@H](C[C@@H]3[C@@H]2C[C@@H](CC3)CO)O<br />
| StdInChI = 1S/C26H42O3/c1-4-5-6-7-12-26(2,3)20-10-11-22(25(29)15-20)24-16-21(28)14-19-9-8-18(17-27)13-23(19)24/h10-11,15,18-19,21,23-24,27-29H,4-9,12-14,16-17H2,1-3H3/t18-,19-,21+,23+,24-/m1/s1<br />
| StdInChIKey = ZAELPWSCABXXAB-QXASVXAKSA-N<br />
}}<br />
<br />
'''CP 55,244''' is a [[chemical compound]] which is a [[cannabinoid]] receptor agonist. It has [[analgesic]] effects and is used in scientific research. It is an extremely potent [[Cannabinoid receptor 1|CB<sub>1</sub>]] full agonist with a [[Dissociation constant|K<sub>i</sub>]] of 0.21&nbsp;nM, making it more potent than the commonly used full agonist [[HU-210]].<ref name="pmid8872458">{{cite journal | vauthors = Melvin LS, Milne GM, Johnson MR, Wilken GH, Howlett AC | title = Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity | journal = Drug Design and Discovery | volume = 13 | issue = 2 | pages = 155–66 | date = November 1995 | pmid = 8872458 | doi = | url = }}</ref><ref>{{cite journal | vauthors = Griffin G, Wray EJ, Martin BR, Abood ME | title = Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum | journal = British Journal of Pharmacology | volume = 128 | issue = 3 | pages = 684–8 | date = October 1999 | pmid = 10516649 | pmc = 1571656 | doi = 10.1038/sj.bjp.0702806 }}</ref><br />
<br />
== See also ==<br />
* [[CP 42,096]]<br />
* [[CP 47,497]]<br />
* [[CP 55,940]]<br />
<br />
== References ==<br />
{{reflist}}<br />
<br />
{{cannabinoids}}<br />
{{Hallucinogens}}<br />
<br />
[[Category:Primary alcohols]]<br />
[[Category:Cyclohexanols]]<br />
[[Category:Cannabinoids]]<br />
[[Category:Decalins]]<br />
[[Category:Drugs developed by Pfizer]]<br />
[[Category:Phenols]]<br />
<br />
{{cannabinoid-stub}}</div>
imported>Arthurfragoso